Latest Breaking News On - Caroline fry - Page 1 : comparemela.com

HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients

HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated Rejection in Kidney Transplant Recipients
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongCaroline fryMorgan warnersUptal patelKatharina mayerHuman immunology biosciences incUnited network for organ sharingUniversity of viennaUniversity viennaDivision of nephrologyEuropean renal associationNew england journalImmunology biosciencesBanff classificationAssociate professor

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress

HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongUptal patelMorgan warnersCaroline fryClinical researchEuropean renal associationAachen universityHuman immunology biosciences incImmunology biosciencesStudy investigatorChief medical officerMonograph capitalAlpha wave globalArkin bio capitalJeito capital

HI-Bio to Present at the 61st European Renal Association (ERA) Congress

HI-Bio to Present at the 61st European Renal Association (ERA) Congress
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Morgan warnersCaroline fryKatharinaa mayerEuropean renal associationHuman immunology biosciences incAachen universityUniversity of viennaImmunology biosciencesIga nephropathyModerated oralsRandomized phaseHumoral transplantLate breaking clinical trialsVictoria hallMedical universityBreakthrough therapy

HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases

HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Travis murdochChris dimitropoulosCaroline fryHuman immunology biosciences incDrug administrationHuman immunology biosciencesAlpha waveViking global investorsArkin bio capitalJeito capitalBreakthrough therapy designationOrphan drug designationManaging directorHealthcare investmentsAlpha wave globalBio board

HI-Bio to Present at the American Society of Nephrology Kidney Week 2023 Annual Meeting

/PRNewswire/ Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies for patients with severe.

United statesHong kongCaroline fryDonna flesherBrad rovinMorgan warnersOhio state universityHuman immunology biosciences incAmerican society of nephrologyPrimary membranous nephropathyImmunology biosciencesAmerican societyKidney weekFinal analysisGlomerular diseasesTranslational studies